H eart failure (HF) is a chronic life-limiting syndrome that negatively impacts health and places a huge burden on patients, families, and society. The morbidity and mortality associated with HF are substantial; the 5-year mortality is 50%, 1,2 and HF contributes to 1 in 9 deaths and more than 1 million hospitalizations each year in the United States. 3 The risk for adverse outcomes in HF is highest around the time of a hospitalization for acute decompensated HF (ADHF), 4 and as a result, HF has the highest 30-day readmission rate of any condition. 5 Optimal disease management is critical to maintaining clinical stability and avoiding adverse outcomes in HF. However, it relies upon a patient"s ability to actively manage his/her health by assimilating multiple tasks into their daily life, 6, 7 such as taking medications as prescribed, adhering to dietary and fluid restrictions, exercising regularly, attending frequent clinical appointments, and recognizing and communicating with their clinicians when problems arise.
Recent studies have suggested that patient activation, or having the knowledge, skills, and confidence to engage in managing one"s own health, favorably impacts patient behaviors and health outcomes. In a general population and in those with chronic illnesses such as diabetes, higher activation has been linked to healthier behaviors, 8 higher use of preventive care, 8 better disease management, 9 lower resource utilization, 9, 10 and lower costs of care. 11 Given the complexity of HF self-care tasks, activated patients with HF may be better prepared to manage their health and, as a result, have better disease management and outcomes. However, the level of activation and association with outcomes in patients with HF has not been thoroughly examined. Therefore, we hypothesized that patient activation would be associated with in-hospital outcomes (length of stay, discharge location, mortality) and early postdischarge outcomes (30-day mortality, 30-day readmission) in HF. As a potentially modifiable factor, 12, 13 if activation is associated with these outcomes, then it may represent a target for intervention.
The aims of this study are to delineate the level of activation of patients hospitalized with ADHF and examine its association with patient characteristics and in-hospital and early postdischarge outcomes.
Methods

Study Design
This is a prospective cohort study that was conducted in Southeastern Minnesota, an area relatively isolated from other urban centers with a limited number of providers, the largest of which is the Mayo Clinic, which delivers most of the medical care to local residents. The Rochester Epidemiology Project, 14 a medical record linkage system, allows the indexing of data for medical care of residents of Southeastern Minnesota, thus enabling the comprehensive capture of health-related events for the community"s residents.
Patient Population
Patients hospitalized with ADHF at Mayo Clinic hospitals in Rochester, Minnesota, were identified using a 2-step process. First, we used a validated natural language processing algorithm to screen electronic clinical notes for terms consistent with HF. 15, 16 Each morning, computerized software screened the text of all notes generated and produced an excel file comprising patients identified as potential HF cases. Then, a research nurse would manually review the medical record of each potential HF patient to determine whether he/she met study entry criteria. Patients were included in the study if they (1) had chronic HF, (2) were currently hospitalized with ADHF meeting Framingham criteria, (3) were at least 20 years old, and (4) were residents of 1 of 7 Southeastern Minnesota counties. Patients were excluded if they were incapable of completing the questionnaires because of mental or physical limitations. From January 21, 2014, through July 14, 2015, patients meeting entry criteria were approached in the hospital and invited to participate. All participants provided written authorization, and the study was approved by the Mayo Clinic Institutional Review Board.
Patient-Reported Data
Immediately after enrollment, participants were administered face-to-face questionnaires by a study coordinator. Activation was measured using the validated 13-item Patient Activation Measure (PAM). 17, 18 According to the developers of the PAM, 18 patients who are activated believe that patients have important roles in maintaining their health, know how to manage their condition and prevent health decline, and have the skills to maintain their health, collaborate with clinicians, and access appropriate care. Examples of items in the PAM include ''I am confident that I can follow through on medical treatments I may need to do at home'' and ''When all is said and done, I am the person who is responsible for taking care of my health.'' A summary score (range, 0Y100), with higher levels indicative of higher activation, is generated based on the responses to the 13 PAM items using a proprietary conversion. Users are provided with a spreadsheet that calculates the PAM summary score upon purchasing a user license. Patients are assigned to 1 of 4 activation levels (1 to 4) based upon the summary score. Level 1 (lowest activation) individuals do not feel in charge of their health and care and may feel disengaged and overwhelmed. Level 2 (lower activation) have some knowledge about their health and condition but are still struggling and feel that their health is largely out of their control. Level 3 patients (high activation) have basic knowledge about their health and condition and some confidence in their ability to manage their health. Level 4 patients (highest activation) have had some success in managing their health and adopting healthy behaviors but may still struggle during times of stress. Health literacy was assessed using the 3-item Health Literacy Screener, 19 with poor health literacy defined as a total score of higher than 10. 20 Overall and financial satisfaction was measured using the general and financial satisfaction subscales of the Patient Satisfaction Questionnaire-18 21 ; scores range from 0 to 5, with higher scores indicating higher satisfaction. Patient-reported health status was assessed using the single question, ''In general, would you say that your health is excellent, very good, good, fair or poor?'' which has been predictive of outcomes in patients with HF. 22 Marital status and education level were obtained by questionnaire.
Patient Characteristics
Other patient characteristics were extracted from their medical records, including demographics, comorbidities, and ejection fraction. The Charlson Comorbidity Index was used to assess comorbidity. 23 Resting left ventricular ejection fraction was collected from transthoracic echocardiograms performed within 6 months before 1 month after study enrollment. Preserved ejection fraction was defined as 50% or greater. 24 
Ascertainment of In-Hospital and Postdischarge Outcomes
In-hospital outcomes examined included length of stay, discharge location, and mortality. Early postdischarge outcomes examined included 30-day readmission and 30-day mortality. To ensure that all participants had the opportunity for at least 30 days of follow-up, participants were followed through August 31, 2015, for all-cause death and readmission. Whether patients were discharged to home, a skilled nursing facility, assisted living facility, or other care arrangement was collected from the medical record. Mortality follow-up was available on all patients. The date of death was determined using death certificates filed in local counties, obituary notices, and electronic files of death certificates obtained from the State of Minnesota Department of Vital and Health Statistics. All readmissions to Mayo Clinic hospitals from the date of discharge to 30 days after discharge were obtained using local administrative sources. The reason for readmission was categorized based on the principal (first) International Classification of Diseases, 9th revision billing code.
Statistical Analysis
For each patient enrolled in the study, patient-reported data, patient characteristics, and outcomes were combined together in a single file for data analysis. Missing data were minimal; most variables were complete and all had less than 1% missing. For descriptive purposes, patient baseline characteristics and outcomes are presented by patient activation level (a 4-level categorical variable). Differences in baseline characteristics across activation levels were compared using generalized linear models for continuous variables and Mantel-Haenszel # 2 for categorical variables. The associations of activation and outcomes were examined using the PAM summary score as a continuous variable. The associations of activation and in-hospital mortality and discharge to nursing home were examined using logistic regression. The association of activation and hospital length of stay was examined using linear regression. Cox proportional hazard regression was used to examine the associations of activation and 30-day outcomes (readmission, mortality). All analyses were performed using Stata Version 13.0 (College Station, Texas).
Results
A total of 375 patients were approached for inclusion in the study, and 302 (80.5%) agreed to participate. Patients were elderly, had a high burden of comorbidities, and 47% had preserved ejection fraction (Table 1) . Almost half (44%) had postYhigh school education, whereas 22% did not graduate high school. Most patients (56%) were married, whereas 24% were widowed, 13% were separated or divorced, and 7% were single/never married.
Patient activation scores ranged from 29 to 100 (median, 53.2; 25thY75th percentile, 48.9Y55.6). The number of patients in each activation category from highest to lowest was 9 (3.0%), 121 (40.1%), 122 (40.4%), and 50 (16.6%). Patients who were less activated were older, were less educated, had worse general and financial satisfaction, and had worse health literacy (Table 1) . Patients who were less activated also more often had a history of depression.
The median (25thY75th percentile) hospital length of stay was 4 (3Y7) days. In total, 7 (2.3%) patients died in the hospital, whereas the remainder were discharged home (n = 217, 73.6%), to assisted living facilities (n = 6, 2.0%), to skilled nursing facilities (n = 70, 23.7%), or to other care arrangements (n = 2, 0.7%). The 30-day readmission rate was 21.7%. The most common reasons for readmission were HF (32.8% of readmissions) and respiratory failure (7.8%). The 30-day mortality rate was 7.0%. Of those who died within 30 days of hospital discharge, 10 (47.6%) died in the hospital, 4 (19.0%) died at home, 5 (23.8%) died in skilled nursing facilities, 1 (4.8%) died in inpatient hospice, and 1 (4.8%) died in an assisted living facility. In total, 12 (57.1%) saw palliative care in consultation in the 2 months before death and 6 (28.6%) enrolled in hospice.
The associations of patient activation and in-hospital and early postdischarge outcomes are shown in Table 2 and the Figure. There was a stepwise increase in the proportion of patients who were discharged to skilled nursing facilities with decreasing activation (P G .001). Even when patients who were residents of skilled nursing facilities on admission where excluded, the proportion of new nursing home discharges still increased with decreasing activation (11.1%, 12.3%, 23.4%, and 32.6% for those with highest to lowest activation, respectively, P G .001). The odds of requiring a skilled nursing facility at hospital discharge was 3.6 (95% confidence interval [CI], 1.7Y7.8) for patients with the lowest activation and 2.2 (1.2Y4.1) for patients with low activation compared with patients with the highest 2 levels of activation. The odds of discharge to a skilled nursing facility increased 10% with each 1-point decrease in PAM (odds ratio [OR], 1.10; 95% CI, 1.05Y1.15; P G .001). The association persisted after adjusting for age and comorbidity (OR, 1.08; 95% CI, 1.03Y1.14; P G .001).
A stepwise increase in 30-day mortality with decreasing activation was also observed. None of the patients who died within 30 days of hospitalization were in the highest activation level, and 81% were in the lowest 2 activation levels. The risk of 30-day mortality was 6.4 (95% CI, 2.1Y23.7) for patients with the lowest activation and 2.2 (95% CI, 0.70Y8.3) for patients with low activation compared with patients with the highest 2 levels of activation. The risk of death increased 10% with each 1-point decrease in PAM (hazard ratio [HR], 1.10; 95% CI, 1.03Y1.17; P = .003). The association persisted after adjusting for age and comorbidity (HR, 1.09; 95% CI, 1.03Y1.16; P = .006). As only 7 patients died during their index hospitalization, the association between activation and in-hospital mortality did not reach statistical significance (OR per 1-point decrease in PAM, 1.10; 95% CI, 0.98Y1.24; P = .095).
The association between patient activation and 30-day readmission was not statistically significant (HR per 1 point decrease in PAM, 0.97; 95% CI, 0.95Y1.01; P = .067), but there was a stepwise increase in 30-day readmission rates in patients with higher activation. However, this was because patients Values shown are n (%), unless otherwise noted. a Patients who experienced out-of-hospital death were assumed to be readmitted on the day of death.
with low activation often died before they could be readmitted. When we assumed that patients who died within 30 days would have been readmitted on the day of death, the 30-day readmission rate was similar across activation levels (33.3%, 24.4%, 23.3%, and 25.5% for those from highest to lowest activation, respectively). No significant association between patient activation and length of stay was observed (" = .06; 95% CI, j.10 to .11; P = .92).
Discussion
We chose to focus on evaluating the association between patient activation and in-hospital and early postdischarge outcomes, as this is a period of enhanced risk in patients with HF 4 where intervention might be beneficial. Among community patients hospitalized with ADHF, low activation was common, particularly in patients who were older, less educated, and with poor health literacy. Lower activation was associated with worse patient satisfaction, increased need for skilled nursing facility care at hospital discharge, and higher 30-day mortality. Patient activation did not differ by comorbidity burden, health status, or ejection fraction and was not predictive of 30-day readmission.
Activation in patients hospitalized with ADHF is lower than has been previously measured in a general ambulatory population 8, 11 and in patients hospitalized in a general medical ward. 10 For example, in a large outpatient primary care population, 4 of 5 patients were in the highest 2 levels of activation, compared with only 2 of 5 in our study. Patients with chronic disease tend to be less activated, 9, 25 although the proportion of patients at the highest activation level in this study (3.0%) was less than has been reported in ambulatory populations. This could reflect that we are capturing a high-risk population, and they may feel a lack of control over their health while in the hospital and over their condition given their acute decompensation.
Similar to others, we found that activation was higher in patients who were younger, 25 ,26 more educated, 10, 25, 26 and in those with better health literacy. 10 Previous HF literature demonstrates that health literacy is associated with enhanced HF knowledge and better self-care, 27, 28 and our results suggest that these patients also have higher activation. The association of activation with age is intriguing but may reflect that older adults with HF frequently have concomitant geriatric syndromes, such as impaired cognition and limitations in functional mobility, 29, 30 that can make self-care and disease management more challenging. Several previous studies have noted that patients who are less activated are more likely to have depression, 10, 25 consistent with our findings. Symptoms associated with depression such as anhedonia, difficulty concentrating, and insomnia can make it more difficult for patients to feel confident in engaging in their healthcare decisions and management. Unlike previous studies, 18, 25, 26, 31 we found no association between activation and health status. However, it is important to note that the health status of patients in this study was quite poor and could explain the variation in our findings compared with prior reports.
Patient Activation and Outcomes
In this study, lower activation was associated with higher 30-day mortality, and patients at the lowest activation level had a more than 6-fold increased risk of death within 30 days of hospital discharge compared with patients in the highest 2 activation levels. To the best of our knowledge, this is the first study to find an association between patient activation and mortality. However, other measures of self-care, such as medication adherence, have been associated with risk of death in patients with chronic conditions including HF. 32, 33 The PAM is easy to administer and could represent a simple way to identify patients at increased risk for death in the early postdischarge period. Notably, half of patients who died within 30 days of hospital discharge saw palliative care specialists in consultation before death and one-quarter enrolled in hospice, likely indicating that clinicians recognized that the patients were approaching the end of life. However, other patients also had unanticipated deaths, and measuring activation during hospitalization may be another trigger for providers to discuss goals of care with patients. It is important to recognize that low activation may not cause death, but rather, patients with HF who are nearing the end of life may be less activated and feel less control over their health.
Second, we found that activation was strongly associated with nursing home placement. PostYacute care use is common after an acute hospitalization and represents a substantial burden to the healthcare system. 34 The need for nursing home care is frequent in patients hospitalized with ADHF; in the Get with the Guidelines program, 24.1% of patients were discharged to a nursing home after hospitalization, 35 which is similar to the 23.7% we observed. Some of these patients only need acute rehabilitation rather than long-term care, and an intervention to improve activation targeting patients discharged to skilled nursing facilities may be of interest to explore in future studies.
We found no association between patient activation and 30-day readmission. This is in contrast to previous studies demonstrating that patients with higher activation are less likely to be hospitalized 9 and rehospitalized. 10 There are potential reasons why our findings vary from previous reports. As previously noted, the health status of patients in this study is worse than in previous studies; patients in this study were plagued with a high symptom and disease burden. Although activation may help to avoid readmissions that could have been prevented by improved medication adherence and disease management, many of the readmissions may have been unavoidable, regardless of activation level.
Finally, we found no association between patient activation and in-hospital mortality or length of stay. However, the in-hospital mortality rate in patients with HF is only 3.3%, 36 which is similar to the 2.3% in our study, and as such, we were limited in our ability to detect a difference in this relatively rare outcome.
Previous work has suggested that patient activation changes over time 11 and can be modified. Interventions to improve activation have had some success. One trial reported that patients randomized to participate in a weekly workshop, covering topics such as dealing with frustration, effective communication techniques, nutrition, and exercise, had greater improvements in activation over 6 weeks compared with a control group. 12 A trial of a nurse-led intervention in 84 patients with HF found that patients randomized to the intervention had increased activation and fewer hospitalizations than the control arm did. 13 This study now demonstrates that lower activation is associated with the need for skilled nursing facility care and 30-day mortality in patients hospitalized with ADHF. Further work is needed to understand if patient activation can increase in response to intervention in this high-risk population and, if so, whether improvement in activation translates into better health outcomes.
Strengths and Limitations
There are limitations that should be acknowledged to aid in interpretation of these data. First, we were limited in our ability to evaluate the associations of activation and infrequent outcomes, such as inhospital mortality, and these findings should be replicated in larger patient populations. Second, this study was performed in a single community, and associations may vary in other geographic areas. However, it should be acknowledged that the characteristics of the local population are similar to those of the state of Minnesota and the Upper Midwest United States. 37 Third, if readmission occurred to a nonMayo hospital, it was not captured. However, the 30-day readmission rate in this study (22%) is very similar to the national 30-day readmission rate for HF (22.7%), making it unlikely that we missed a large number of readmissions. Conversely, there are several notable strengths. To the best of our knowledge, this is the first study to investigate the associations of activation and outcomes in patients with hospitalized with ADHF. We were able to assess activation and several other key constructs such as patient satisfaction and health literacy in a group of high-risk patients with HF.
Conclusions
Most patients hospitalized with ADHF have low activation and therefore lack the skills, confidence, and motivation to manage their own health. Those with lower activation are less satisfied with their care, more often require skilled care at hospital discharge, and have higher 30-day mortality. Future studies are needed to understand whether interventions can improve patient activation in this high-risk population.
What"s New and Important h More than half of patients hospitalized with ADHF are in the lowest 2 levels of activation. h Low activation is more common in patients who are older and less educated and with poor health literacy. h Patients hospitalized with ADHF with lower activation are less satisfied and are more likely to require skilled nursing facility care at hospital discharge and to die within 30 days of hospitalization.
